Genetracer Biotech participated in 2016 in the European Molecular Genetics Quality Network (EMQN) whith two external quality assessment schemes: NextGen DNA Sequencing (vGermline) NextGen DNA Sequencing (vSomatic) Both of them where passed with satisfactory result.
Fluxion Biosciences Appoints Genetracer Biotech of Spain As an Isoflux Liquid Biopsy Certified Service Provider
Genetracer Biotech will utilize Fluxion's IsoFlux circulating tumor cell (CTC) system to provide NGS-based liquid biopsy services for lung and colon cancers. More information
Genetracer Biotech continues exploring various international markets through the “Programa de Asesores Comerciales en Destino” organized by ICEX Next. In this context, Genetracer biotech hosted the visit from the commercial advisor Mexico. With this meeting, Genetracer Biotech has started the Phase 1 of the program. [...]
Genetracer Biotech has participated for the second consecutive year as EQA Assessor Scheme for Lung cancer
Between 12 and 15 October and based on experience gained in the field of oncology, Genetracer Biotech has participated as EQA (External Quality Assessment) Assessor Scheme for lung cancer. The objective is annual provision of EQA schemes which meet international quality standards. The overall aim is improvement [...]
Genetracer Biotech has started the exploration of the Ecuadorian market with Phase 1 of the Program Commercial Advisors promoted by ICEX-NEXT
After the good experience with our previous contact with the “Programa de Asesores Comerciales en Destino” promoted by the ICEX-Next, Genetracer Biotech pursues contacts with different Commercial Advisors. Early October, was developed the Phase 1 of the program for Ecuador’s market. Genetracer expects to complete [...]
Based on the strategic plan for internationalization developed by Genetracer Biotech, the last September was launched the Peru’s Program Commercial Advisors to explore the emerging Peruvian market (the initiative launched by the ICEX-Next).
Last June, Genetracer Biotech has participated as an ICEX's company in the “Programa de Asesores Comerciales en Destino”. The main objective of this program is to create a strategy to optimize resource allocation for market access. In this context, Genetracer Biotech supported by ICEX Next, [...]
During the year 2016 Genetracer Biotech has obtained the classification as INNOVATIVE SMEs given by the Dirección General de Innovación y Competitividad del Ministerio de Economía y Competitividad. Innovative SMEs - Ministry of Economy and Competitiveness
Photo: Meeting with the Ambassador of Spain in Cuba, Juan Francisco Montalban. Genetracer Biotech was present between 3 and 8 July in Cuba participating with SODERCAN group, in a comercial mission. This trade mission had the cooperation of the Economic and Commercial Office of the [...]
Scientific and financial solvency of the company Genetracer Biotech is guaranteed by the National Innovation Company (ENISA), giving their support and trust. Enisa Web Enisa Firms May 2016